Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Wasmuth

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
HIV Medicine|April 19, 2003
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapyJ-C Wasmuth, F Hackbarth, J K Rockstroh, et al.
Cellular and Molecular Neurobiology|February 1, 1996
Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitaryE Fuchs, J C Wasmuth, G Flügge, et al.
Journal of Chromatographic Science|January 30, 2010
Determination of nevirapine in plasma by GC-MSM Vogel, N Bertram, J C Wasmuth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosisJ C Wasmuth, K H Klein, F Hackbarth, et al.
Infection|April 2, 2004
Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.
European Journal of Medical Research|January 16, 2003
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infectionJ-C Wasmuth, K Schliefer, C Scheurlen, et al.
European Journal of Clinical Pharmacology|August 11, 2007
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.
European Journal of Medical Research|May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infectionL Leifeld, J Rockstroh, S Skaide, et al.
European Journal of Medical Research|November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysisB Terjung, F Bogsch, R Klein, et al.
European Journal of Medical Research|October 16, 2007
Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoringJ-C Wasmuth, E Rodermann, E Voigt, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
HIV Medicine|April 19, 2003
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapyJ-C Wasmuth, F Hackbarth, J K Rockstroh, et al.
Cellular and Molecular Neurobiology|February 1, 1996
Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitaryE Fuchs, J C Wasmuth, G Flügge, et al.
Journal of Chromatographic Science|January 30, 2010
Determination of nevirapine in plasma by GC-MSM Vogel, N Bertram, J C Wasmuth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosisJ C Wasmuth, K H Klein, F Hackbarth, et al.
Infection|April 2, 2004
Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week resultsE Voigt, J-C Wasmuth, M Vogel, et al.
European Journal of Medical Research|January 16, 2003
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infectionJ-C Wasmuth, K Schliefer, C Scheurlen, et al.
European Journal of Clinical Pharmacology|August 11, 2007
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicityJ-C Wasmuth, I Lambertz, E Voigt, et al.
European Journal of Medical Research|May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infectionL Leifeld, J Rockstroh, S Skaide, et al.
European Journal of Medical Research|November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysisB Terjung, F Bogsch, R Klein, et al.
European Journal of Medical Research|October 16, 2007
Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoringJ-C Wasmuth, E Rodermann, E Voigt, et al.
Pageof 5